Global Duloxetine Active Pharmaceutical Ingredients (API) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Q: What are the significant segments operating in the market?

Market is segmented on the basis. Read More

Global Duloxetine Active Pharmaceutical Ingredients (API) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID : 279649
Published On: Mar, 2022
Pages: 156
Pharmaceuticals and Healthcare

Buy @ $3500

The Duloxetine Active Pharmaceutical Ingredients (API) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Duloxetine Active Pharmaceutical Ingredients (API) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pharmaceutical and Biotechnology Industries accounting for % of the Duloxetine Active Pharmaceutical Ingredients (API) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Major Depression Drug segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Duloxetine Active Pharmaceutical Ingredients (API) include Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Aurobindo Pharma (India), Lupin (India), and Zydus Cadila (India), etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Duloxetine Active Pharmaceutical Ingredients (API) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Major Depression Drug

Generalized Anxiety Disorder Drug

Fibromyalgia Drugs

Neuropathic Pain Medication

Other

Market segment by Application can be divided into

Pharmaceutical and Biotechnology Industries

Hospital

Other

The key market players for global Duloxetine Active Pharmaceutical Ingredients (API) market are listed below:

Teva Pharmaceutical Industries Ltd (Israel)

Sun Pharmaceutical Industries Ltd (India)

Aurobindo Pharma (India)

Lupin (India)

Zydus Cadila (India)

Eli Lilly and Company (United States)

Shodhana Laboratories (India)

Hetero (India)

Apotex (Canada)

Shionogi (US)

Zhejiang Huahai Pharmaceutical (China)

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Duloxetine Active Pharmaceutical Ingredients (API) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Duloxetine Active Pharmaceutical Ingredients (API), with price, sales, revenue and global market share of Duloxetine Active Pharmaceutical Ingredients (API) from 2019 to 2022.

Chapter 3, the Duloxetine Active Pharmaceutical Ingredients (API) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Duloxetine Active Pharmaceutical Ingredients (API) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Duloxetine Active Pharmaceutical Ingredients (API) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Duloxetine Active Pharmaceutical Ingredients (API).

Chapter 13, 14, and 15, to describe Duloxetine Active Pharmaceutical Ingredients (API) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

What are the significant segments operating in the market?

Market is segmented on the basis:

By Type
By Application
By Region
By Country
By Manufacturer

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Duloxetine Active Pharmaceutical Ingredients (API) Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Major Depression Drug

1.2.3 Generalized Anxiety Disorder Drug

1.2.4 Fibromyalgia Drugs

1.2.5 Neuropathic Pain Medication

1.2.6 Other

1.3 Market Analysis by Application

1.3.1 Overview: Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Pharmaceutical and Biotechnology Industries

1.3.3 Hospital

1.3.4 Other

1.4 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size & Forecast

1.4.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume (2017-2028)

1.4.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Price (2017-2028)

1.5 Global Duloxetine Active Pharmaceutical Ingredients (API) Production Capacity Analysis

1.5.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Total Production Capacity (2017-2028)

1.5.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Duloxetine Active Pharmaceutical Ingredients (API) Market Drivers

1.6.2 Duloxetine Active Pharmaceutical Ingredients (API) Market Restraints

1.6.3 Duloxetine Active Pharmaceutical Ingredients (API) Trends Analysis

2 Manufacturers Profiles

2.1 Teva Pharmaceutical Industries Ltd (Israel)

2.1.1 Teva Pharmaceutical Industries Ltd (Israel) Details

2.1.2 Teva Pharmaceutical Industries Ltd (Israel) Major Business

2.1.3 Teva Pharmaceutical Industries Ltd (Israel) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

2.1.4 Teva Pharmaceutical Industries Ltd (Israel) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Sun Pharmaceutical Industries Ltd (India)

2.2.1 Sun Pharmaceutical Industries Ltd (India) Details

2.2.2 Sun Pharmaceutical Industries Ltd (India) Major Business

2.2.3 Sun Pharmaceutical Industries Ltd (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

2.2.4 Sun Pharmaceutical Industries Ltd (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Aurobindo Pharma (India)

2.3.1 Aurobindo Pharma (India) Details

2.3.2 Aurobindo Pharma (India) Major Business

2.3.3 Aurobindo Pharma (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

2.3.4 Aurobindo Pharma (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Lupin (India)

2.4.1 Lupin (India) Details

2.4.2 Lupin (India) Major Business

2.4.3 Lupin (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

2.4.4 Lupin (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Zydus Cadila (India)

2.5.1 Zydus Cadila (India) Details

2.5.2 Zydus Cadila (India) Major Business

2.5.3 Zydus Cadila (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

2.5.4 Zydus Cadila (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Eli Lilly and Company (United States)

2.6.1 Eli Lilly and Company (United States) Details

2.6.2 Eli Lilly and Company (United States) Major Business

2.6.3 Eli Lilly and Company (United States) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

2.6.4 Eli Lilly and Company (United States) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Shodhana Laboratories (India)

2.7.1 Shodhana Laboratories (India) Details

2.7.2 Shodhana Laboratories (India) Major Business

2.7.3 Shodhana Laboratories (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

2.7.4 Shodhana Laboratories (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 Hetero (India)

2.8.1 Hetero (India) Details

2.8.2 Hetero (India) Major Business

2.8.3 Hetero (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

2.8.4 Hetero (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9 Apotex (Canada)

2.9.1 Apotex (Canada) Details

2.9.2 Apotex (Canada) Major Business

2.9.3 Apotex (Canada) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

2.9.4 Apotex (Canada) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10 Shionogi (US)

2.10.1 Shionogi (US) Details

2.10.2 Shionogi (US) Major Business

2.10.3 Shionogi (US) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

2.10.4 Shionogi (US) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11 Zhejiang Huahai Pharmaceutical (China)

2.11.1 Zhejiang Huahai Pharmaceutical (China) Details

2.11.2 Zhejiang Huahai Pharmaceutical (China) Major Business

2.11.3 Zhejiang Huahai Pharmaceutical (China) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

2.11.4 Zhejiang Huahai Pharmaceutical (China) Duloxetine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Duloxetine Active Pharmaceutical Ingredients (API) Breakdown Data by Manufacturer

3.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Duloxetine Active Pharmaceutical Ingredients (API)

3.4 Market Concentration Rate

3.4.1 Top 3 Duloxetine Active Pharmaceutical Ingredients (API) Manufacturer Market Share in 2021

3.4.2 Top 6 Duloxetine Active Pharmaceutical Ingredients (API) Manufacturer Market Share in 2021

3.5 Global Duloxetine Active Pharmaceutical Ingredients (API) Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Duloxetine Active Pharmaceutical Ingredients (API) Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Region

4.1.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2017-2028)

4.1.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2028)

4.2 North America Duloxetine Active Pharmaceutical Ingredients (API) Revenue (2017-2028)

4.3 Europe Duloxetine Active Pharmaceutical Ingredients (API) Revenue (2017-2028)

4.4 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Revenue (2017-2028)

4.5 South America Duloxetine Active Pharmaceutical Ingredients (API) Revenue (2017-2028)

4.6 Middle East and Africa Duloxetine Active Pharmaceutical Ingredients (API) Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Type (2017-2028)

5.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2028)

5.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Application (2017-2028)

6.2 Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2028)

6.3 Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)

7.2 North America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)

7.3 North America Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Country

7.3.1 North America Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028)

7.3.2 North America Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)

8.2 Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)

8.3 Europe Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Country

8.3.1 Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028)

8.3.2 Europe Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)

9.2 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)

9.3 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Region

9.3.1 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)

10.2 South America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)

10.3 South America Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Country

10.3.1 South America Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028)

10.3.2 South America Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)

11.2 Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)

11.3 Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Market Size by Country

11.3.1 Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Duloxetine Active Pharmaceutical Ingredients (API) and Key Manufacturers

12.2 Manufacturing Costs Percentage of Duloxetine Active Pharmaceutical Ingredients (API)

12.3 Duloxetine Active Pharmaceutical Ingredients (API) Production Process

12.4 Duloxetine Active Pharmaceutical Ingredients (API) Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Duloxetine Active Pharmaceutical Ingredients (API) Typical Distributors

13.3 Duloxetine Active Pharmaceutical Ingredients (API) Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Teva Pharmaceutical Industries Ltd (Israel) Basic Information, Manufacturing Base and Competitors

Table 4. Teva Pharmaceutical Industries Ltd (Israel) Major Business

Table 5. Teva Pharmaceutical Industries Ltd (Israel) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

Table 6. Teva Pharmaceutical Industries Ltd (Israel) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Sun Pharmaceutical Industries Ltd (India) Basic Information, Manufacturing Base and Competitors

Table 8. Sun Pharmaceutical Industries Ltd (India) Major Business

Table 9. Sun Pharmaceutical Industries Ltd (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

Table 10. Sun Pharmaceutical Industries Ltd (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Aurobindo Pharma (India) Basic Information, Manufacturing Base and Competitors

Table 12. Aurobindo Pharma (India) Major Business

Table 13. Aurobindo Pharma (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

Table 14. Aurobindo Pharma (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Lupin (India) Basic Information, Manufacturing Base and Competitors

Table 16. Lupin (India) Major Business

Table 17. Lupin (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

Table 18. Lupin (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Zydus Cadila (India) Basic Information, Manufacturing Base and Competitors

Table 20. Zydus Cadila (India) Major Business

Table 21. Zydus Cadila (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

Table 22. Zydus Cadila (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Eli Lilly and Company (United States) Basic Information, Manufacturing Base and Competitors

Table 24. Eli Lilly and Company (United States) Major Business

Table 25. Eli Lilly and Company (United States) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

Table 26. Eli Lilly and Company (United States) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Shodhana Laboratories (India) Basic Information, Manufacturing Base and Competitors

Table 28. Shodhana Laboratories (India) Major Business

Table 29. Shodhana Laboratories (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

Table 30. Shodhana Laboratories (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. Hetero (India) Basic Information, Manufacturing Base and Competitors

Table 32. Hetero (India) Major Business

Table 33. Hetero (India) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

Table 34. Hetero (India) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Apotex (Canada) Basic Information, Manufacturing Base and Competitors

Table 36. Apotex (Canada) Major Business

Table 37. Apotex (Canada) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

Table 38. Apotex (Canada) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 39. Shionogi (US) Basic Information, Manufacturing Base and Competitors

Table 40. Shionogi (US) Major Business

Table 41. Shionogi (US) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

Table 42. Shionogi (US) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 43. Zhejiang Huahai Pharmaceutical (China) Basic Information, Manufacturing Base and Competitors

Table 44. Zhejiang Huahai Pharmaceutical (China) Major Business

Table 45. Zhejiang Huahai Pharmaceutical (China) Duloxetine Active Pharmaceutical Ingredients (API) Product and Services

Table 46. Zhejiang Huahai Pharmaceutical (China) Duloxetine Active Pharmaceutical Ingredients (API) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 47. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)

Table 48. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 49. Market Position of Manufacturers in Duloxetine Active Pharmaceutical Ingredients (API), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 50. Global Duloxetine Active Pharmaceutical Ingredients (API) Production Capacity by Company, (MT): 2020 VS 2021

Table 51. Head Office and Duloxetine Active Pharmaceutical Ingredients (API) Production Site of Key Manufacturer

Table 52. Duloxetine Active Pharmaceutical Ingredients (API) New Entrant and Capacity Expansion Plans

Table 53. Duloxetine Active Pharmaceutical Ingredients (API) Mergers & Acquisitions in the Past Five Years

Table 54. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Region (2017-2022) & (MT)

Table 55. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Region (2023-2028) & (MT)

Table 56. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2022) & (USD Million)

Table 57. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Region (2023-2028) & (USD Million)

Table 58. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (MT)

Table 59. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (MT)

Table 60. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2022) & (USD Million)

Table 61. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Type (2023-2028) & (USD Million)

Table 62. Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Type (2017-2022) & (USD/MT)

Table 63. Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Type (2023-2028) & (USD/MT)

Table 64. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (MT)

Table 65. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (MT)

Table 66. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2022) & (USD Million)

Table 67. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Application (2023-2028) & (USD Million)

Table 68. Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Application (2017-2022) & (USD/MT)

Table 69. Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Application (2023-2028) & (USD/MT)

Table 70. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country (2017-2022) & (MT)

Table 71. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country (2023-2028) & (MT)

Table 72. North America Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2022) & (USD Million)

Table 73. North America Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2023-2028) & (USD Million)

Table 74. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (MT)

Table 75. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (MT)

Table 76. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (MT)

Table 77. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (MT)

Table 78. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country (2017-2022) & (MT)

Table 79. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country (2023-2028) & (MT)

Table 80. Europe Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2022) & (USD Million)

Table 81. Europe Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2023-2028) & (USD Million)

Table 82. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (MT)

Table 83. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (MT)

Table 84. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (MT)

Table 85. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (MT)

Table 86. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales by Region (2017-2022) & (MT)

Table 87. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales by Region (2023-2028) & (MT)

Table 88. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2022) & (USD Million)

Table 89. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Region (2023-2028) & (USD Million)

Table 90. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (MT)

Table 91. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (MT)

Table 92. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (MT)

Table 93. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (MT)

Table 94. South America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country (2017-2022) & (MT)

Table 95. South America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Country (2023-2028) & (MT)

Table 96. South America Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2022) & (USD Million)

Table 97. South America Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Country (2023-2028) & (USD Million)

Table 98. South America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (MT)

Table 99. South America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (MT)

Table 100. South America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (MT)

Table 101. South America Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (MT)

Table 102. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales by Region (2017-2022) & (MT)

Table 103. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales by Region (2023-2028) & (MT)

Table 104. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2022) & (USD Million)

Table 105. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Revenue by Region (2023-2028) & (USD Million)

Table 106. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (MT)

Table 107. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (MT)

Table 108. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (MT)

Table 109. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (MT)

Table 110. Duloxetine Active Pharmaceutical Ingredients (API) Raw Material

Table 111. Key Manufacturers of Duloxetine Active Pharmaceutical Ingredients (API) Raw Materials

Table 112. Direct Channel Pros & Cons

Table 113. Indirect Channel Pros & Cons

Table 114. Duloxetine Active Pharmaceutical Ingredients (API) Typical Distributors

Table 115. Duloxetine Active Pharmaceutical Ingredients (API) Typical Customers

List of Figures

Figure 1. Duloxetine Active Pharmaceutical Ingredients (API) Picture

Figure 2. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Type in 2021

Figure 3. Major Depression Drug

Figure 4. Generalized Anxiety Disorder Drug

Figure 5. Fibromyalgia Drugs

Figure 6. Neuropathic Pain Medication

Figure 7. Other

Figure 8. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Application in 2021

Figure 9. Pharmaceutical and Biotechnology Industries

Figure 10. Hospital

Figure 11. Other

Figure 12. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue, (USD Million) & (MT): 2017 & 2021 & 2028

Figure 13. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales (2017-2028) & (MT)

Figure 15. Global Duloxetine Active Pharmaceutical Ingredients (API) Price (2017-2028) & (USD/MT)

Figure 16. Global Duloxetine Active Pharmaceutical Ingredients (API) Production Capacity (2017-2028) & (MT)

Figure 17. Global Duloxetine Active Pharmaceutical Ingredients (API) Production Capacity by Geographic Region: 2022 VS 2028

Figure 18. Duloxetine Active Pharmaceutical Ingredients (API) Market Drivers

Figure 19. Duloxetine Active Pharmaceutical Ingredients (API) Market Restraints

Figure 20. Duloxetine Active Pharmaceutical Ingredients (API) Market Trends

Figure 21. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturer in 2021

Figure 22. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturer in 2021

Figure 23. Duloxetine Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 24. Top 3 Duloxetine Active Pharmaceutical Ingredients (API) Manufacturer (Revenue) Market Share in 2021

Figure 25. Top 6 Duloxetine Active Pharmaceutical Ingredients (API) Manufacturer (Revenue) Market Share in 2021

Figure 26. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2017-2028)

Figure 27. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2017-2028)

Figure 28. North America Duloxetine Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (USD Million)

Figure 29. Europe Duloxetine Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (USD Million)

Figure 30. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (USD Million)

Figure 31. South America Duloxetine Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (USD Million)

Figure 32. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (USD Million)

Figure 33. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)

Figure 34. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2017-2028)

Figure 35. Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Type (2017-2028) & (USD/MT)

Figure 36. Global Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 37. Global Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2017-2028)

Figure 38. Global Duloxetine Active Pharmaceutical Ingredients (API) Price by Application (2017-2028) & (USD/MT)

Figure 39. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)

Figure 40. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 41. North America Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2017-2028)

Figure 42. North America Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2017-2028)

Figure 43. United States Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Canada Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Mexico Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)

Figure 47. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 48. Europe Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2017-2028)

Figure 49. Europe Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2017-2028)

Figure 50. Germany Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. France Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. United Kingdom Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Russia Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Italy Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2017-2028)

Figure 56. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 57. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2017-2028)

Figure 58. Asia-Pacific Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2017-2028)

Figure 59. China Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Japan Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Korea Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. India Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Southeast Asia Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Australia Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South America Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)

Figure 66. South America Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 67. South America Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2017-2028)

Figure 68. South America Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)

Figure 72. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 73. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2017-2028)

Figure 74. Middle East & Africa Duloxetine Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2017-2028)

Figure 75. Turkey Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Egypt Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. South Africa Duloxetine Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Manufacturing Cost Structure Analysis of Duloxetine Active Pharmaceutical Ingredients (API) in 2021

Figure 80. Manufacturing Process Analysis of Duloxetine Active Pharmaceutical Ingredients (API)

Figure 81. Duloxetine Active Pharmaceutical Ingredients (API) Industrial Chain

Figure 82. Sales Channel: Direct Channel vs Indirect Channel

Figure 83. Methodology

Figure 84. Research Process and Data Source

License Type

Quick Contact

Our Clients

Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz